Updates in the management of Guillain Barre Syndrome Repository

Updates in the management of Guillain Barre Syndrome

Novi Chandra Imelda, - and Fadil Baktir, - and Fidiana, - and Hanik Badriyah Hidayati, - (2018) Updates in the management of Guillain Barre Syndrome. Anaesth, Pain & Intensive Care, 22 (Supp1). pp. 54-57. ISSN 16078322

	Text (Artikel) Bukti C-05 GBS.pdf Download (296kB)
	Text (Peer Review) Bukti C-05 Peer Review.pdf Download (1MB)
	Text (Similarity) Bukti C-05 GBS.pdf Download (1MB)
	Text (Bukti Korespondensi) 3.pdf Download (142kB)

Official URL: http://www.apicareonline.com/index.php/APIC/articl...

Abstract

Barré and Strohl in 1916. Although GBS has a good prognosis (5% mortality rate), about 10% of patients experience serious disability one year after the start of neurological onset. Recent research of GBS shows that the process involves a number of subtypes with different immunological mechanism and a spectrum of clinical syndrome of acute inflammatory neuropathy. Antibodies against peripheral nerve gangliosides and their own complements are recognized as an important mechanism of nerve damage in GBS. Pharmacokinetics of intravenous immunoglobulin (IVIg) therapy and other related factors that influence prognosis has been researched. In order to investigate the possible role of complement inhibition in GBS management, new studies will be conducted. The management of GBS should be provided in appropriate hospital units, with specialist teams, intensive care and rehabilitation facilities as essential parts. This article aims to provide updated management of GBS.

Item Type:

Article

Uncontrolled Keywords:

Guillain-Barre syndrome, GBS, Management, Immunotherapy

Subjects:

R Medicine > R Medicine (General)
R Medicine > RC Internal medicine

Divisions:

01. Fakultas Kedokteran > Ilmu Penyakit Saraf
Artikel Ilmiah > SCOPUS INDEXED JOURNAL

Creators: